Q-omics provides the consensus-scored SPATA31D2P profile across patient tissues and cancer cell-line models. SPATA31D2P expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in LIHC. Additionally, SPATA31D2P RNA expression shows 5,933 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight LIHC, and STAD as cancer lineages where SPATA31D2P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for SPATA31D2P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes SPATA31D2P survival associations across molecular data types. SPATA31D2P RNA expression shows survival associations in the most cancer types (8). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

SPATA31D2P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	8	LIHC (27)	view →

This table ranks reproducible SPATA31D2P RNA expression–survival associations across cancer types. High SPATA31D2P expression shows unfavorable associations in LIHC, DLBC, PAAD, THCA and ESCA, but favorable associations in LUSC. The LIHC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LIHC as the clearest survival context for SPATA31D2P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	II,III,IV	0.121	0.627	<.001	27	view →
DLBC	DFS	Tertile	II,III,IV	0.357	0.876	.010	21	view →
PAAD	OS	Tertile	All	0.132	0.590	<.001	18	view →
THCA	DFS	Tertile	IV	0.126	0.805	.002	18	view →
LUSC	DFS	Tertile	III,IV	1.000	0.333	.018	12	view →
ESCA	OS	Tertile	All	0.598	0.895	.043	9	view →

Pink = unfavorable, green = favorable. all 8 lineages →

SPATA31D2P-LIHC (OS)

Kaplan–Meier survival curve for SPATA31D2P RNA expression in LIHC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with SPATA31D2P in patient tissues and cancer cell lines. In patient samples, SPATA31D2P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	5,933	STAD (5753)	view →
RNA	2,919	COAD (1263)	view →